Which enzyme is used to assess hepatocellular disorder?

Which enzyme is used to assess hepatocellular disorder?

• A. GGT
• B. ALP
• C. ALT
• D. Troponin

Answer: (C)

The assessment of hepatocellular disorders focuses on the evaluation of liver function and integrity, particularly in identifying conditions such as hepatitis, cirrhosis, or liver injury. The enzyme that is most commonly used for this purpose is alanine aminotransferase (ALT). ALT is primarily found in the liver, and when liver cells are damaged, ALT is released into the bloodstream. A significant elevation in ALT levels typically indicates liver cell injury, making it a critical marker for evaluating hepatocellular function. This makes ALT a key enzyme in the diagnosis and monitoring of liver diseases. While gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) can be elevated in liver conditions, they are less specific for hepatocellular damage compared to ALT. GGT is often used to assess biliary tract diseases and alcohol-induced liver injury, and ALP is typically associated with cholestasis rather than direct liver cell damage. Troponin, on the other hand, is a biomarker used primarily in the context of cardiac injury and is not relevant to liver function assessment. Thus, ALT is recognized as the most indicative enzyme for assessing hepatocellular disorders, aligning with the context of liver health evaluation.

The assessment of hepatocellular disorders focuses on the evaluation of liver function and integrity, particularly in identifying conditions such as hepatitis, cirrhosis, or liver injury. The enzyme that is most commonly used for this purpose is alanine aminotransferase (ALT).

ALT is primarily found in the liver, and when liver cells are damaged, ALT is released into the bloodstream. A significant elevation in ALT levels typically indicates liver cell injury, making it a critical marker for evaluating hepatocellular function. This makes ALT a key enzyme in the diagnosis and monitoring of liver diseases.

While gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) can be elevated in liver conditions, they are less specific for hepatocellular damage compared to ALT. GGT is often used to assess biliary tract diseases and alcohol-induced liver injury, and ALP is typically associated with cholestasis rather than direct liver cell damage. Troponin, on the other hand, is a biomarker used primarily in the context of cardiac injury and is not relevant to liver function assessment.

Thus, ALT is recognized as the most indicative enzyme for assessing hepatocellular disorders, aligning with the context of liver health evaluation.